Abstract
Candida is an important cause of fungal endophthalmitis that can lead to serious blinding complications. Although uncommon in developed countries, it represents an important clinical problem in the developing world due to its potential for significant visual loss despite aggressive therapy. Immunocompromised patients are at a particular risk of developing the disease. Often, long-term therapy with systemic antifungal agents and debulking surgeries such as pars plana vitrectomy may be required in order to salvage vision. The following chapter will discuss the protean clinical course and management of four cases of Candida endophthalmitis.
Suggested Reading
Chakrabarti A, Shivaprakash MR, Singh R, Tarai B, George VK, Fomda BA, Gupta A. Fungal endophthalmitis: fourteen years’ experience from a center in India. Retina. 2008;28(10):1400–7.
Sallam A, Lynn W, McCluskey P, Lightman S. Endogenous Candida endophthalmitis. Expert Rev Anti Infect Ther. 2006;4(4):675–85.
Shah CP, McKey J, Spirn MJ, Maguire J. Ocular candidiasis: a review. Br J Ophthalmol. 2008;92(4):466–8.
Vinekar A, Dogra MR, Avadhani K, Gupta V, Gupta A, Chakrabarti A. Management of recurrent postoperative fungal endophthalmitis. Indian J Ophthalmol. 2014;62(2):136–40.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer India
About this entry
Cite this entry
Sadiq, M.A., Agarwal, A., Gupta, V., Dogra, M.R., Gupta, A., Nguyen, Q.D. (2016). Candida Retinochoroiditis. In: Gupta, V., Nguyen, Q., LeHoang, P., Herbort Jr., C. (eds) The Uveitis Atlas. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2506-5_35-1
Download citation
DOI: https://doi.org/10.1007/978-81-322-2506-5_35-1
Received:
Accepted:
Published:
Publisher Name: Springer, New Delhi
Online ISBN: 978-81-322-2506-5
eBook Packages: Springer Reference MedicineReference Module Medicine